Cargando…
Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge
Nearly four million yearly deaths can be attributed to respiratory diseases, prompting a huge worldwide health emergency. Additionally, the COVID-19 pandemic’s death toll has surpassed six million, significantly increasing respiratory disease morbidity and mortality rates. Despite recent advances, i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322090/ https://www.ncbi.nlm.nih.gov/pubmed/35890341 http://dx.doi.org/10.3390/pharmaceutics14071447 |
_version_ | 1784756211671891968 |
---|---|
author | Areny-Balagueró, Aina Mekseriwattana, Wid Camprubí-Rimblas, Marta Stephany, Andrea Roldan, Ariana Solé-Porta, Anna Artigas, Antonio Closa, Daniel Roig, Anna |
author_facet | Areny-Balagueró, Aina Mekseriwattana, Wid Camprubí-Rimblas, Marta Stephany, Andrea Roldan, Ariana Solé-Porta, Anna Artigas, Antonio Closa, Daniel Roig, Anna |
author_sort | Areny-Balagueró, Aina |
collection | PubMed |
description | Nearly four million yearly deaths can be attributed to respiratory diseases, prompting a huge worldwide health emergency. Additionally, the COVID-19 pandemic’s death toll has surpassed six million, significantly increasing respiratory disease morbidity and mortality rates. Despite recent advances, it is still challenging for many drugs to be homogeneously distributed throughout the lungs, and specifically to reach the lower respiratory tract with an accurate sustained dose and minimal systemic side effects. Engineered nanocarriers can provide increased therapeutic efficacy while lessening potential biochemical adverse reactions. Poly(lactic-co-glycolic acid) (PLGA), a biodegradable polymer, has attracted significant interest as an inhalable drug delivery system. However, the influence of the nanocarrier surface charge and its intratracheal instillation has not been addressed so far. In this study, we fabricated red fluorescent PLGA nanocapsules (NCs)—Cy5/PLGA—with either positive (Cy5/PLGA+) or negative surface charge (Cy5/PLGA-). We report here on their excellent colloidal stability in culture and biological media, and after cryo-storage. Their lack of cytotoxicity in two relevant lung cell types, even for concentrations as high as 10 mg/mL, is also reported. More importantly, differences in the NCs’ cell uptake rates and internalization capacity were identified. The uptake of the anionic system was faster and in much higher amounts—10-fold and 2.5-fold in macrophages and epithelial alveolar cells, respectively. The in vivo study demonstrated that anionic PLGA NCs were retained in all lung lobules after 1 h of being intratracheally instilled, and were found to accumulate in lung macrophages after 24 h, making those nanocarriers especially suitable as a pulmonary immunomodulatory delivery system with a marked translational character. |
format | Online Article Text |
id | pubmed-9322090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93220902022-07-27 Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge Areny-Balagueró, Aina Mekseriwattana, Wid Camprubí-Rimblas, Marta Stephany, Andrea Roldan, Ariana Solé-Porta, Anna Artigas, Antonio Closa, Daniel Roig, Anna Pharmaceutics Article Nearly four million yearly deaths can be attributed to respiratory diseases, prompting a huge worldwide health emergency. Additionally, the COVID-19 pandemic’s death toll has surpassed six million, significantly increasing respiratory disease morbidity and mortality rates. Despite recent advances, it is still challenging for many drugs to be homogeneously distributed throughout the lungs, and specifically to reach the lower respiratory tract with an accurate sustained dose and minimal systemic side effects. Engineered nanocarriers can provide increased therapeutic efficacy while lessening potential biochemical adverse reactions. Poly(lactic-co-glycolic acid) (PLGA), a biodegradable polymer, has attracted significant interest as an inhalable drug delivery system. However, the influence of the nanocarrier surface charge and its intratracheal instillation has not been addressed so far. In this study, we fabricated red fluorescent PLGA nanocapsules (NCs)—Cy5/PLGA—with either positive (Cy5/PLGA+) or negative surface charge (Cy5/PLGA-). We report here on their excellent colloidal stability in culture and biological media, and after cryo-storage. Their lack of cytotoxicity in two relevant lung cell types, even for concentrations as high as 10 mg/mL, is also reported. More importantly, differences in the NCs’ cell uptake rates and internalization capacity were identified. The uptake of the anionic system was faster and in much higher amounts—10-fold and 2.5-fold in macrophages and epithelial alveolar cells, respectively. The in vivo study demonstrated that anionic PLGA NCs were retained in all lung lobules after 1 h of being intratracheally instilled, and were found to accumulate in lung macrophages after 24 h, making those nanocarriers especially suitable as a pulmonary immunomodulatory delivery system with a marked translational character. MDPI 2022-07-11 /pmc/articles/PMC9322090/ /pubmed/35890341 http://dx.doi.org/10.3390/pharmaceutics14071447 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Areny-Balagueró, Aina Mekseriwattana, Wid Camprubí-Rimblas, Marta Stephany, Andrea Roldan, Ariana Solé-Porta, Anna Artigas, Antonio Closa, Daniel Roig, Anna Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge |
title | Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge |
title_full | Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge |
title_fullStr | Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge |
title_full_unstemmed | Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge |
title_short | Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge |
title_sort | fluorescent plga nanocarriers for pulmonary administration: influence of the surface charge |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322090/ https://www.ncbi.nlm.nih.gov/pubmed/35890341 http://dx.doi.org/10.3390/pharmaceutics14071447 |
work_keys_str_mv | AT arenybalagueroaina fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge AT mekseriwattanawid fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge AT camprubirimblasmarta fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge AT stephanyandrea fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge AT roldanariana fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge AT soleportaanna fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge AT artigasantonio fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge AT closadaniel fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge AT roiganna fluorescentplgananocarriersforpulmonaryadministrationinfluenceofthesurfacecharge |